Search In this Thesis
   Search In this Thesis  
العنوان
Sick Euthyroid Syndrome In Prevalent Hemodialysis Patients/
المؤلف
Abd El Rahman ,Nahla Hussein
هيئة الاعداد
باحث / نهلة حسين عبد الرحمن
مشرف / محمد علي ابراهيم
مشرف / عصام محمد عبد الحفيظ
تاريخ النشر
2017
عدد الصفحات
121.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب الباطني
تاريخ الإجازة
1/1/2017
مكان الإجازة
جامعة عين شمس - كلية الطب - Internal Medicine
الفهرس
Only 14 pages are availabe for public view

from 121

from 121

Abstract

Numerous abnormalities of thyroid hormones in end-stage renal disease (ESRD) have been described, one of these abnormalities is sick euthyroid syndrome.The aim of the study is to assess the frequency of sick euthyroid syndrome in prevalent hemodialysis patients .patients and methods: forty stable prevalent hemodialysis patients were randomly selected from Ain shams university hemodialysis unit and all were subjected to full history and detailed clinical examination especially thyroid gland , CBC , thyroid profile fT3 , fT4 , TSH and rT3 (by ELISA) as well as thyroid ultrasound.Exclusion criteria included patients with known thyroid disorders or receiving drugs affecting thyroid functions.The studied population was divided into 2 groups according to level of fT3 , 27 (67.5%)patients had low fT3 and 13(32.5%) patients had normal level of fT3.there was no statistically significant difference between the 2 groups as regard demographic , laboratory and ultrasound data. The studied population was divided into another 2 groups according to level of rT3.Patients with high level of rT3 had high prevalence of thyroid nodules.Conclusion : there is high prevalence of sick euthyroid syndrome in hemodialysis patients, patients with SES had higher incidence with thyroid nodules which may have prognostic value as nodules may be precancerous.Recommendation: studying risk factors which may lead to SES, follow up the patients with thyroid nodules.
Keywords : thyroid disorders , hemodialysis , sick euthyroid syndrome, thyroid nodules , reverse T3.